NEWTON, Mass.--(BUSINESS WIRE)--March 17, 2006--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate-based therapeutic compounds, today announced that its abstract has been accepted for publication in The American Society of Cancer Oncology’s (ASCO) 2006 Annual Meeting Proceedings, which is a supplement to the Journal of Clinical Oncology. The ASCO Annual Meeting will be held in Atlanta, Georgia, June 2-6.
